What medications are used for mycoplasma pneumonia?

Sep 18, 2025 Source: Cainiu Health

Dr. Ren Yi

Introduction

In general, mycoplasma pneumonia is caused by infection with Mycoplasma pneumoniae, and common symptoms include fever, cough, fatigue, etc. Patients may take medications such as azithromycin dispersible tablets, doxycycline hydrochloride tablets, levofloxacin tablets, roxithromycin capsules, and clarithromycin tablets as directed by a physician. It is advisable to maintain good indoor ventilation and avoid crowded places.

Generally, Mycoplasma pneumonia is caused by infection with *Mycoplasma pneumoniae*, and common symptoms include fever, cough, fatigue, and others. Patients may follow medical advice to use medications such as azithromycin dispersible tablets, doxycycline hydrochloride tablets, levofloxacin tablets, roxithromycin capsules, and clarithromycin tablets for treatment. Detailed analysis is as follows:

1. Azithromycin Dispersible Tablets

This medication belongs to the macrolide class of antibiotics. It inhibits protein synthesis in *Mycoplasma pneumoniae*, preventing pathogen replication and thereby controlling infection. It has strong antibacterial activity against *Mycoplasma pneumoniae* and is suitable for both adult and pediatric patients with Mycoplasma pneumonia, especially those allergic to penicillin.

2. Doxycycline Hydrochloride Tablets

This is a tetracycline-class antibiotic that interferes with DNA replication and protein synthesis in *Mycoplasma pneumoniae*, exerting its antibacterial effect. It is suitable for adults and children over 8 years old with Mycoplasma pneumonia and remains effective against strains resistant to macrolide antibiotics.

3. Levofloxacin Tablets

This drug belongs to the quinolone class of antibiotics. It inhibits DNA gyrase in *Mycoplasma pneumoniae*, blocking DNA replication and effectively killing the pathogen. With broad-spectrum and potent antibacterial activity, it is indicated for adult patients with Mycoplasma pneumonia. However, it should be avoided in children and adolescents.

4. Roxithromycin Capsules

A macrolide antibiotic, roxithromycin works similarly to azithromycin by inhibiting protein synthesis in *Mycoplasma pneumoniae* to control infection. It has strong penetration into respiratory mucosa and is suitable for both adult and pediatric patients with Mycoplasma pneumonia, particularly those with mild disease.

5. Clarithromycin Tablets

Also a macrolide antibiotic, clarithromycin specifically binds to the ribosomal subunits of *Mycoplasma pneumoniae*, inhibiting protein synthesis and exerting antibacterial effects. It is suitable for both adults and children with Mycoplasma pneumonia and retains some activity against certain *Mycoplasma pneumoniae* strains resistant to azithromycin.

In daily life, ensure good indoor ventilation and avoid crowded places. Cover your mouth and nose with a tissue when coughing to prevent pathogen transmission. During treatment, get adequate rest, drink plenty of fluids, avoid overexertion, and support recovery.

View All

What is Mycoplasma pneumoniae?

Under normal circumstances, Mycoplasma pneumoniae is a microorganism that lies between bacteria and viruses. Mycoplasma pneumoniae is a small microorganism that exists between ciliated epithelial cells. It adheres to the surface of host respiratory epithelial cells through neuraminic acid receptor sites on the cell membrane, inhibiting ciliary activity and damaging epithelial cells. It is generally recommended to maintain good indoor air circulation and keep warm.

View Full Answer

Can Mycoplasma pneumonia cause white lung?

Mycoplasma pneumoniae may lead to white lung. In some special cases, Mycoplasma pneumoniae infection might cause severe pulmonary lesions, resulting in white lung. If Mycoplasma pneumoniae infection is not timely controlled, the inflammation may continue to worsen, with large amounts of inflammatory exudates accumulating in the alveoli and pulmonary interstitium. When the exudates reach a certain level, the lungs may exhibit white areas on imaging studies.